1. A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancer
   Duntao Su et al, 2022, Front. Genet. CrossRef
2. Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
   Zixuan Zhong et al, 2022, Pathol. Oncol. Res. CrossRef
3. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance
   Mehrdad Hashemi et al, 2022, Pharmacological Research CrossRef
4. Identification of a CD4+ conventional T cells-related lncRNAs signature associated with hepatocellular carcinoma prognosis, therapy, and tumor microenvironment
   Lin Zhu et al, 2023, Front. Immunol. CrossRef
5. Construction and verification of a novel circadian clock related long non-coding RNA model and prediction of treatment for survival prognosis in patients with hepatocellular carcinoma
   Zhen Zhang et al, 2023, BMC Cancer CrossRef
6. Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma
   Yi Fu et al, 2023, BMC Genomics CrossRef
7. A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification
   Li Yang et al, 2023, BMC Gastroenterol CrossRef
8. Creation of a Prognostic Model Using Cuproptosis-Associated Long Noncoding RNAs in Hepatocellular Carcinoma
   Lihong Yang et al, 2023, IJMS CrossRef
9. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma
   Shuo Wang et al, 2023, Biochem Genet CrossRef
10. A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility
    Yanqiong Liu et al, 2024, Sci Rep CrossRef
11. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma
    Ren-Yong Wang et al, 2024, World J Gastroenterol CrossRef
12. Prognosis and chemotherapy drug sensitivity in liver hepatocellular carcinoma through a disulfidptosis-related lncRNA signature
    Chao Chen et al, 2024, Sci Rep CrossRef
13. Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior
    Xuefeng Gu et al, 2024, BMC Cancer CrossRef
14. A disulfidptosis-related lncRNA signature for analyzing tumor microenvironment and clinical prognosis in hepatocellular carcinoma
    Haishui Zheng et al, 2024, Front. Immunol. CrossRef